Skip to content

The community pharmacy setting for diabetes prevention: views and perceptions of stakeholders

Research output: Contribution to journalArticle

Original languageEnglish
JournalPLoS ONE
DateAccepted/In press - 30 Jun 2019
DatePublished (current) - 18 Jul 2019

Abstract

Background: Diabetes prevention programmes delay or prevent the onset of type 2 diabetes in people with pre-diabetes. To increase accessibility, national guidelines recommend delivering diabetes prevention programmes in primary care settings, including community pharmacy. This study aimed to explore the English community pharmacy setting as an option for delivering diabetes prevention services.

Methods: Two focus groups and nine semi-structured interviews were conducted with stakeholders including, community pharmacists, general practitioners and commissioners. The topic guide was framed using the COM-B theoretical model for behaviour change to elicit practitioners’ capability, opportunity and motivation to engage with providing or referring to community pharmacy diabetes prevention services. Data were analysed thematically, and barriers/facilitators mapped to the COM-B framework.

Results: Five themes were identified: ‘Pre-diabetes management and associated challenges’, ‘The community pharmacy setting’, ‘Awareness of community pharmacy services’, ‘Relationships and communication’ and ‘Delivery of community pharmacy services’. Community pharmacy was highlighted as an accessible setting for delivering screening and follow-on lifestyle interventions. Key factors for enhancing the capability of community pharmacy teams to deliver the interventions included training and appropriate use of skill mix. Delivering diabetes prevention services in collaboration with general practices was identified as key to the provision of integrated primary care services. Whilst financial incentives were identified as a motivating factor for delivery, service promotion to patients, public and healthcare professionals was perceived as crucial for enhancing engagement.

Conclusions: This research highlights a role for community pharmacy in diabetes prevention. New service models should seek to integrate community pharmacy services in primary care to facilitate patient engagement and better communication with general practices.

Documents

Documents

  • PONE-D-19-11830R1_FTC (Thando's paper)

    Accepted author manuscript, 127 KB, Word document

    Request copy

    Licence: CC BY

  • journal.pone.0219686 - Thando et al (2019) - diabetes prevention in pharmacy - stakeholder paper

    Final published version, 424 KB, PDF document

    Request copy

    Licence: CC BY

View research connections

Related faculties, schools or groups